Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

12.5%

2 terminated out of 16 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

31%

5 trials in Phase 3/4

Results Transparency

17%

2 of 12 completed with results

Key Signals

2 with results86% success

Data Visualizations

Phase Distribution

12Total
P 1 (1)
P 2 (6)
P 3 (3)
P 4 (2)

Trial Status

Completed12
Unknown2
Terminated2

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT04950712CompletedPrimary

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

NCT04165122Phase 2CompletedPrimary

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection

NCT04664127Completed

Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel

NCT00079911Phase 4TerminatedPrimary

A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons

NCT04073082UnknownPrimary

Safety and Efficacy of Laser Therapy in Gynaecology

NCT02837575Phase 2CompletedPrimary

Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine

NCT00158860Phase 4CompletedPrimary

A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

NCT00486200Phase 2CompletedPrimary

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

NCT02852876Phase 1CompletedPrimary

Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food

NCT00405821Phase 2Completed

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda

NCT00076232Phase 3Completed

A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

NCT00122525Phase 3Terminated

Effect of Male Circumcision on HIV Incidence (ANRS 1265)

NCT00158483Phase 2Completed

Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)

NCT00023582Completed

HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, Peru

NCT00158509Phase 2CompletedPrimary

Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding

NCT00005663Phase 3Unknown

A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

Showing all 16 trials

Research Network

Activity Timeline